Beacon Medicare Ltd. introduced another block buster drugs Obetix for Cirrhosis Treatment


Beacon Medicare Ltd. introduced another block buster drugs Obetix for Cirrhosis Treatment

  • BEACON introduced a Farnesoid X Receptor agonist, Obeticholic Acid, under the brand name of Obetix for the treatment of Primary Biliary Cirrhosis .

  • Obetix is a general drug in oral tablet preparation available in the strength of 5 mg.

  • This product is only for export.

To know more visit our website: www.Obetix.com